Oxford University is undertaking a human challenge trial to see how easily people can be reinfected with SARS-CoV-2, which causes COVID-19. It will recruit 64 volunteers aged between 18 and 30 to discover what dose of the virus can cause…
#COVID19 #coronavirus #vaccines During this lecture we will be discussing COVID-19 vaccines including Moderna, Pfizer/BioNTech, and Astrazeneca/Oxford. We are NOT sponsored and/or endorsed by Moderna, Pfizer/BioNTech, or Astrazeneca. We are presenting on RESEARCH and in no way is any of…
The last two weeks have seen a string of encouraging results from COVID-19 vaccine trials with several experimental vaccines having proved over 90% effectiveness at preventing disease in late-stage clinical trials. Let’s find out if the hunt for the vaccine…
The coronavirus vaccine developed by teams at the University of Oxford has been shown to trigger a robust immune response in healthy adults aged 56-69 and those over 70 years of age. The findings published in ‘Lancet’ on Thursday based…
New research has detected the presence of ‘autoantibodies’ in some COVID-19 survivors. These autoantibodies attack the human genetic material rather than the virus cells, leading to long-term illness. Watch this video to find out what is the treatment and why…
A volunteer participating in clinical trials of the Covid-19 vaccine developed by Oxford University has died in Brazil, officials announced Wednesday, though media reports said he had received a placebo, not the test vaccine. It is the first death reported…
